DARS™ Stock Ratings for NVS

If you were a Dividend.com Premium member, you would be seeing detailed DARS™ Dividend Stock Ratings information for Novartis (NVS) in this space. Sign up for Dividend.com Premium today to gain access to ratings on nearly 2,000 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!

Subscribe to Dividend.com Premium Today! »

Recent Dividend.com Articles for NVS

• Latest Dividend Notes (OXY, DVN, COST, NVS, more)
  Mon, Oct 19, 2009
• New Additions to the Recommended List 10/15
  Thu, Oct 15, 2009
• ActiveStocks.com - Paul's Playbook
  Fri, Jul 17, 2009
• ActiveStocks.com - Playbook Follow-Up
  Thu, Jul 16, 2009
• ActiveStocks.com - Paul's Playbook
  Thu, Jul 16, 2009
• Dividend Highlights and Lowlights for May.13
  Wed, May 13, 2009
• Dividend Payout Changes for Jan.28
  Wed, Jan 28, 2009
• Dividend Highlights and Lowlights for Jan.28
  Wed, Jan 28, 2009
• Market Wrap-Up for Jan.28
  Wed, Jan 28, 2009
• Novartis Shares Fall Despite 70% Profit Growth in Q4 and Dividend Raise (NVS)
  Wed, Jan 28, 2009
• Novartis Streamlines Divisions to Focus on U.S. Markets (NVS)
  Mon, Oct 20, 2008
• Potential Ban on Kids Cold Remedies May Affect Pharmaceutical Sector (JNJ, WYE, NVS, PG)
  Thu, Oct 2, 2008
• 28 (!) Dividend Stocks Removed from Our Recommended List
  Tue, Sep 9, 2008
• Dividend Stock Recommendation Changes (NVS, SQM, MOS, CHK, FRO, CAJ, BUCY, PWE, APA, OSG, BPT, NTE)
  Mon, Aug 4, 2008
• Novartis Can Relieve Investor Stress (NVS)
  Mon, Aug 4, 2008

Company Profile & Recommendation

Company Profile

Novartis- (NVS)- provides healthcare solutions that address the needs of patients and societies worldwide. Its Pharmaceuticals division researches, develops, manufactures, distributes, and sells pharmaceuticals in therapeutic areas, including cardiovascular and metabolism; oncology and hematology; neuroscience; respiratory; infectious diseases, transplantation, and immunology; ophthalmics, dermatology, gastrointestinal, and urinary; and arthritis and bone. The company's Vaccines and Diagnostics division focuses on the development of preventive vaccine treatments and diagnostic tools. It offers meningococcal, pediatric, and travel vaccines; and blood testing and molecular diagnostics for preventing the spread of infectious diseases. Novartis' Sandoz division develops, produces, and markets drugs, as well as pharmaceutical and biotechnological active substances. Its Consumer Health division includes three units: Over-The-Counter Medicines (OTC), Animal Health, and CIBA Vision. OTC unit offers self medications; Animal Health unit provides veterinary products for farm and companion animals; and CIBA Vision unit markets contact lenses, lens care products, and ophthalmic products. Novartis has strategic alliance with Morphosys AG for the discovery and development of biopharmaceuticals. The company was founded in 1895 and is headquartered in Basel, Switzerland.

* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.

** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.

*** All dividend payout and date information on this website is for information purposes only. We do not guarantee the accuracy of any dividend dates or payout amounts. Always check with your broker first before purchasing any security.